Analysis: Persistent Systems Limited

NSE:PERSISTENT IT - ER&D Market cap: ₹88.4K cr

Growth thesis

Persistent Systems is no longer a pure standalone compounder story. Q2 FY27 annualised revenue of about $1.95 billion, a 26th sequential growth quarter and a 15% EBIT margin establish a high-quality digital engineering business, but the near-term equity story is now dominated by the Nagarro acquisition, its $1.25 billion financing and the integration of a lower-margin European asset. The thesis is that Persistent can close Nagarro with 94.04% already secured, lift the combined group above $2.9 billion of revenue and 46,000 people, and apply its engineering and AI platform model to Nagarro's European base without permanently sacrificing the 16-17% EBIT margin aspiration. This is a special-situation thesis because the outcome depends on regulatory approvals, financing terms and integration, not only on organic demand.

The core business economics remain attractive. Persistent does product engineering and digital transformation for software, hi-tech, BFSI and healthcare clients. That work is embedded in client product lifecycles, regulatory systems and data estates, which creates switching costs and gives Persistent a seat in large transformation programmes. Q2 FY27 revenue was $487.6 million, up 7.8% QoQ and 20% YoY; rupee revenue rose 30.3%. The top five customers grew 38.9% YoY and the top 100 contribute roughly 82% of revenue. Persistent is not a pure headcount contractor: SASVA, iAURA and GenAI Hub are used to compress engineering and data cycles, and Software Reinvention Services now bundles product engineering, cost reduction and revenue-share constructs for software companies. Management says recent Software Reinvention programmes brought products to market about 50% faster, improved client time to market by more than 25% and reduced running costs by 45% for one marquee client. Those claims are management-reported outcomes, not audited segment economics.

The earnings path has three visible engines. First, the $650 million-plus, 6.5-year deal with an existing US technology customer is converting; management says 75-80% or more would have ramped by Q2 FY27 and Q2 hi-tech growth of 28.5% reflects it. Second, Software Reinvention and AI platform-led delivery can lift revenue per employee if outcome-based pricing scales faster than headcount. Third, Nagarro adds about $1.14 billion trailing revenue, 18,500 professionals and European delivery, taking the combined group above $2.9 billion revenue and 46,000 people. The first two engines are already in the Q2 numbers. The third is not: it depends on closing, which management still expects in Q4 CY26 or Q1 CY27 after Austria, Spain and RBI approvals.

The margin path is the main tension. Q2 FY27 EBIT margin was 15.0%, down 100 basis points QoQ. Wage hikes cost 180 basis points gross and about 140 net; lower utilisation cost 20 basis points; about $4 million of quarterly amortisation on third-party tools and licences in the large deal cost 90 basis points; lower engineering day expenses and currency added 150 basis points. Management expects the large-deal amortisation to reduce gradually as costs are optimised and revenue scales. It still calls 16-17% an aspiration, not guidance, and the Q2 call gives no deadline. My inference is that reaching 16-17% requires both the large-deal amortisation to fall and Nagarro's lower margin to move toward Persistent's level; neither is yet demonstrated.

Capital allocation is now the largest variable. Persistent had secured about 94.04% of Nagarro shares by 6 October 2026, so acceptance risk is largely gone. It still needs Austria, Spain and RBI approvals, and it plans $1.25 billion of debt and equity, including $450 million equity or equity-linked instruments, to replace the €1.4 billion bridge. Acquisition debt was indicated at 5-6% net if raised now. Leverage is guided at 1.9x-2.5x net debt to combined EBITDA at close, reducing to 1x by FY2030. The equity component could dilute, and the bridge plus corporate guarantee sit on Persistent's balance sheet before closing. Against that, cash and investments were ₹29,996.7 million, billed DSO fell to 50 days and TTM OCF/PAT improved to 96.6%, giving more internal funding capacity than a year ago.

Management delivery is credible but not flawless. It delivered the FY26 margin leg and the healthcare recovery, and the large-deal revenue ramp appears to have happened. It missed the OCF-above-100% aspiration for FY26, reframed the $2 billion target from annual revenue to a Q4 FY27 exit run-rate, and has revised its June 2026 no-QIP stance into a $450 million equity component. Those are not trivial changes; they argue for treating management targets as aspirations until evidenced, not as certainty.

The milestones that would validate the thesis are concrete: Austria, Spain and RBI approvals; closing in Q4 CY26 or Q1 CY27; completion of the $1.25 billion financing on non-dilutive or modestly dilutive terms; a squeeze-out; and evidence that Nagarro's revenue stabilises and its margin moves up. The falsifiers are equally concrete: a regulatory delay past CY2027, a costly equity raise, failure to lift Nagarro's margin, continued Europe client-specific declines, or large-deal amortisation that does not fall as revenue scales. If those occur, the 26-quarter growth streak can continue while the equity story still de-rates on lower earnings quality.

Why is Persistent Systems Limited stock rising?

  • Persistent had secured 94.04% of Nagarro shares by 6 October 2026, above the 50% plus one share threshold, and intends a squeeze-out. The EGM approved a $1.25 billion debt-and-equity financing including $450 million equity; closing is expected in Q4 CY26 or Q1 CY27 after Austria, Spain and RBI approvals. Nagarro adds $1.14 billion trailing revenue and 18,500 people, taking the presented group above $2.9 billion revenue and 46,000 people.
  • Management says 75-80% or more of the $650 million-plus, 6.5-year deal would have ramped by Q2 FY27 and Q2 hi-tech growth of 28.5% reflects conversion. Management also confirmed the deal was included in Q1 TCV, correcting a misreading. Software Reinvention adds outcome-based pricing with assured client cost savings and revenue share.
  • Persistent holds nearly 25,000 partner certifications and more than 58,000 AI certifications, and became a preferred partner in Anthropic's Cloud Partner Network Services track while earning Microsoft's Agentic Business Solutions specialisation. Software Reinvention uses SASVA to cut one marquee client's product running cost by 45% and bring products to market about 50% faster.
  • TTM OCF/PAT improved to 96.6% from 76.2%, billed DSO fell to 50 days from 61, and cash and investments rose to ₹29,996.7 million. Record collections give Persistent more internal funding capacity for the $450 million Nagarro equity component while the bridge is in place.
  • Healthcare and Life Sciences grew 12% YoY in Q2 FY27 after FY26 growth of 10.1%, and management said healthcare should start seeing growth with a good pipeline and customer-specific dynamics largely baked in. That gives the group a third vertical alongside hi-tech and BFSI.

Research report

companyname: Persistent Systems Limited ticker: PERSISTENT sector: IT Services / Digital Engineering Persistent Systems is a global technology services company that helps large enterprises build, modernise, and operate software systems, with AI embedded across the entire lifecycle. It was founded in 1990 in Pune by Anand Deshpande. FY26 revenue was $1.654 billion; at Q2 FY27 it employed 29,598 people and reported $487.6 million revenue, up 7.8% QoQ and 20% YoY, the 26th consecutive sequential g...

Read the full report →

Catalysts

geographic expansion, order book surge, acquisition inorganic

Growth guidance

No quantitative revenue or EPS guidance. Management calls 16-17% EBIT margin an aspiration, not guidance, and expects Nagarro closing in Q4 CY26 or Q1 CY27 plus $25-30 million of additional transaction costs, with the cost timing described as both two and three-to-four quarters.

Management consistency

overdeliver

RS rating: 70 Stage: Stage 2

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Persistent Systems Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.